Xu Dong Yin
Direktor/Vorstandsmitglied bei LAEKNA, INC.
Profil
Xu Dong Yin is currently a Director at Novartis New Zealand Ltd., NeuExCell Therapeutics, Inc., and Laekna, Inc. He previously worked as a Director Manager at Boston Consulting (Shanghai) Co. Ltd.
from 2000 to 2004, as the President-AstraZeneca China at AstraZeneca PLC from 2004 to 2011, and as the Head-Asia Pacific, Middle East & Africa Regions at Novartis Pharmaceuticals Corp.
from 2011 to 2021.
Dr. Yin holds an MBA from Harvard University, a doctorate from Stanford University, and an undergraduate degree from Peking University.
Aktive Positionen von Xu Dong Yin
| Unternehmen | Position | Beginn |
|---|---|---|
| LAEKNA, INC. | Direktor/Vorstandsmitglied | - |
Novartis New Zealand Ltd.
 Novartis New Zealand Ltd. Medical DistributorsDistribution Services Novartis New Zealand Ltd. engages in the import, marketing and wholesale of pharmaceutical and animal health products. The company is headquartered in Auckland, New Zealand. | Direktor/Vorstandsmitglied | - |
NeuExCell Therapeutics, Inc.
 NeuExCell Therapeutics, Inc. Medical/Nursing ServicesHealth Services NeuExCell Therapeutics, Inc. operates as a biotechnology company. The company is headquartered in State College, PA. | Direktor/Vorstandsmitglied | - |
Ehemalige bekannte Positionen von Xu Dong Yin
| Unternehmen | Position | Ende |
|---|---|---|
Novartis Pharmaceuticals Corp.
 Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Novartis Pharmaceuticals Corp. develops, manufactures, and markets prescription drugs. It manufactures and markets prescription drugs used to treat a number of diseases and conditions including cardiovascular, dermatological, central nervous system, bone disease, cancer, organ transplantation, psychiatry, infectious disease, and respiratory. The company was founded in 1996 and is headquartered in East Hanover, NJ. | Corporate Officer/Principal | 01.12.2021 |
| ASTRAZENECA PLC | Corporate Officer/Principal | 01.01.2011 |
| Boston Consulting (Shanghai) Co. Ltd. | Corporate Officer/Principal | 01.02.2004 |
Ausbildung von Xu Dong Yin
| Peking University | Undergraduate Degree |
| Stanford University | Doctorate Degree |
| Harvard University | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| LAEKNA, INC. | Health Technology |
| ASTRAZENECA PLC | Health Technology |
| Private Unternehmen | 4 |
|---|---|
Novartis New Zealand Ltd.
Novartis New Zealand Ltd. Medical DistributorsDistribution Services Novartis New Zealand Ltd. engages in the import, marketing and wholesale of pharmaceutical and animal health products. The company is headquartered in Auckland, New Zealand. | Distribution Services |
NeuExCell Therapeutics, Inc.
NeuExCell Therapeutics, Inc. Medical/Nursing ServicesHealth Services NeuExCell Therapeutics, Inc. operates as a biotechnology company. The company is headquartered in State College, PA. | Health Services |
| Boston Consulting (Shanghai) Co. Ltd. | |
Novartis Pharmaceuticals Corp.
Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Novartis Pharmaceuticals Corp. develops, manufactures, and markets prescription drugs. It manufactures and markets prescription drugs used to treat a number of diseases and conditions including cardiovascular, dermatological, central nervous system, bone disease, cancer, organ transplantation, psychiatry, infectious disease, and respiratory. The company was founded in 1996 and is headquartered in East Hanover, NJ. | Health Technology |
